Related references
Note: Only part of the references are listed.Involvement of epidermal growth factor receptor overexpression in the promotion of breast cancer brain metastasis
Fang Nie et al.
CANCER (2012)
DIAPH3 governs the cellular transition to the amoeboid tumour phenotype
Martin H. Hager et al.
EMBO MOLECULAR MEDICINE (2012)
TIEG1 Inhibits Breast Cancer Invasion and Metastasis by Inhibition of Epidermal Growth Factor Receptor (EGFR) Transcription and the EGFR Signaling Pathway
Wei Jin et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer
S. Samanta et al.
ONCOGENE (2012)
Functional Analysis of a Breast Cancer-Associated Mutation in the Intracellular Domain of the Metalloprotease ADAM12
Dorte Stautz et al.
PLOS ONE (2012)
Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy
Parvin F. Peddi et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2012)
Triple negative breast cancer: unmet medical needs
Sumanta Kumar Pal et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
ADAM12 Transmembrane and Secreted Isoforms Promote Breast Tumor Growth A DISTINCT ROLE FOR ADAM12-S PROTEIN IN TUMOR METASTASIS
Roopali Roy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
ADAM12 Produced by Tumor Cells Rather than Stromal Cells Accelerates Breast Tumor Progression
Camilla Frohlich et al.
MOLECULAR CANCER RESEARCH (2011)
Directed Therapy of Subtypes of Triple-Negative Breast Cancer
Lisa A. Carey
ONCOLOGIST (2011)
Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer
Alfonso Sanchez-Munoz et al.
BMC CANCER (2010)
Triple-negative breast cancer: disease entity or title of convenience?
Lisa Carey et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
EGFR signaling in breast cancer: Bad to the bone
John Foley et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Aleix Prat et al.
BREAST CANCER RESEARCH (2010)
Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer
B. Corkery et al.
ANNALS OF ONCOLOGY (2009)
Pattern of metastatic spread in triple-negative breast cancer
Rebecca Dent et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Invasive ductal carcinoma of the breast with the triple-negative phenotype: prognostic implications of EGFR immunoreactivity
Giuseppe Viale et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Microarray-Based Determination of Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Status in Breast Cancer
Paul Roepman et al.
CLINICAL CANCER RESEARCH (2009)
Role of ADAMS in Cancer Formation and Progression
Michael J. Duffy et al.
CLINICAL CANCER RESEARCH (2009)
ErbB receptors and signaling pathways in cancer
Nancy E. Hynes et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
The role of protease activity in ErbB biology
Carl R. Blobel et al.
EXPERIMENTAL CELL RESEARCH (2009)
ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis
Xin Lu et al.
GENES & DEVELOPMENT (2009)
Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer
J. B. Arnes et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Genes that mediate breast cancer metastasis to the brain
Paula D. Bos et al.
NATURE (2009)
MOLECULAR ORIGINS OF CANCER Gene-Expression Signatures in Breast Cancer
Christos Sotiriou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Functional selectivity of EGF family peptide growth factors: Implications for cancer
Kristy J. Wilson et al.
PHARMACOLOGY & THERAPEUTICS (2009)
An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ
Fariba Behbod et al.
BREAST CANCER RESEARCH (2009)
ADAM-17 predicts adverse outcome in patients with breast cancer
P. M. McGowan et al.
ANNALS OF ONCOLOGY (2008)
The humoral immune system has a key prognostic impact in node-negative breast cancer
Marcus Schmidt et al.
CANCER RESEARCH (2008)
HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer
Michael F. Press et al.
CLINICAL CANCER RESEARCH (2008)
Cellular roles of ADAM12 in health and disease
Marie Kveiborg et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Breast cancer-associated mutations in metalloprotease disintegrin ADAM12 interfere with the intracellular trafficking and processing of the protein
Emilia Dyczynska et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
ErbB4/HER4: Role in mammary gland development, differentiation and growth inhibition
Rebecca S. Muraoka-Cook et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
The ADAM metalloproteinases
Dylan R. Edwards et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
Christine Desmedt et al.
CLINICAL CANCER RESEARCH (2007)
Lung metastasis genes couple breast tumor size and metastatic spread
Andy J. Minn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Targeting TACE-dependent EGFR ligand shedding in breast cancer
Paraic A. Kenny et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx
Keisuke Horiuchi et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival
Laura G. Fulford et al.
BREAST CANCER RESEARCH (2007)
The consensus coding sequences of human breast and colorectal cancers
Tobias Sjoeblom et al.
SCIENCE (2006)
EGFR amplification and lack of activating mutations in metaplastic breast carcinomas
J. S. Reis et al.
JOURNAL OF PATHOLOGY (2006)
Frequent overexpression of epidermal growth factor receptor (EGFR) in mammary high grade ductal carcinomas with myoepithelial differentiation
T Shien et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin
MD Sternlicht et al.
DEVELOPMENT (2005)
EGFR gene amplification in breast cancer:: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations
R Bhargava et al.
MODERN PATHOLOGY (2005)
A role for ADAM12 in breast tumor progression and stromal cell apoptosis
M Kveiborg et al.
CANCER RESEARCH (2005)
Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands
U Sahin et al.
JOURNAL OF CELL BIOLOGY (2004)
Analysis of microarray data using Z score transformation
C Cheadle et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2003)
Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion
ZM Lu et al.
CANCER CELL (2003)
Intracellular processing of metalloprotease disintegrin ADAM12
Y Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Tumor necrosis factor-α converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability
SW Sunnarborg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase
ZM Lu et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ
FR Miller et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
The ErbB signaling network: receptor heterodimerization in development and cancer
MA Olayioye et al.
EMBO JOURNAL (2000)
Share Paper
